Gotham founds cancer research prize

Two hedge fund managers have joined forces with scientists to launch a $1 million prize for cancer research.
MAY 23, 2007
Two hedge fund managers have joined forces with scientists to launch a $1 million prize for cancer research. Joel Greenblatt and Robert Goldstein of Gotham Capital in New York have teamed up with Dr. Gary Curhan of Harvard Medical School to create the Gotham Prize for Cancer Research. The award, to be given annually, will go to researchers with groundbreaking ideas in the prevention, etiology, diagnosis and treatment of cancer. Additional support came from Ephi Gildor of Axiom Investment Advisors and the Ira Sohn Conference Foundation, which was named after a Wall Street trader who died of cancer. The foundation also awards an annual $250,000 prize in pediatric oncology. Mr. Goldstein was inspired to create the Gotham Prize after his mother, Hope Goldstein, died from ovarian cancer. This year’s Gotham Prize winners will be announced in February 2008.

Latest News

Mesirow acquires part of flexPATH in second retirement deal of 2026
Mesirow acquires part of flexPATH in second retirement deal of 2026

Chicago-based Mesirow Fiduciary Solutions adds flexPATH's plan-level outsourced fiduciary book, boosting its retirement market reach to $164 billion.

Advisor moves: LPL lands $350M veteran advisor duo in Florida
Advisor moves: LPL lands $350M veteran advisor duo in Florida

Also, Raymond James's employee advisor channel adds breakaways from Wells Fargo and Stifel, while UBS welcomes an ex-Morgan Stanley duo in Indiana.

SEC accuses crypto firm founder of running $425 million Ponzi scheme
SEC accuses crypto firm founder of running $425 million Ponzi scheme

It promised guaranteed principal and 10% monthly returns. The SEC says it invested nothing.

MassMutual Ascend tops $2 billion in RIA annuity sales as advisors warm to income products
MassMutual Ascend tops $2 billion in RIA annuity sales as advisors warm to income products

Ten years after entering the fee-based annuity market, MassMutual Ascend says nearly half its lifetime sales came in the past two years alone – but barriers remain among fee-only advisors.

Fintech bytes: Wealth tech firms target advisor productivity with new integrations
Fintech bytes: Wealth tech firms target advisor productivity with new integrations

Amplify, WealthReach, Zeplyn and Zocks have unveiled partnerships aimed at automating portfolio management, content creation, account opening, and client communication.

SPONSORED Direct indexing webinar targets tax-loss harvesting amid market swings

Northern Trust’s Ken Lassner shows advisors how to convert volatility into after-tax portfolio gains

SPONSORED Who builds the income when the pension disappears?

Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income